Skip to main content
Caplight Logo









Lepidext

Lepidext

Private
Lexington, KentuckyHealthcare & Life Scienceshttps://www.lepidext.com/

Last Round

Series A

Oct 1, 2025

Total Funding Raised

$722,635

Company Overview

Lepidext is an agricultural chemicals company that has developed a biological, active ingredient to control one of the most damaging agricultural pests of corn, cotton, soybeans and many other important crops.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Government Contracts

AI Layer

Non-AI

Keywords

biological pest controlbioinsecticidepest sterilizationagtechagricultural biotechnologyinsect resistance managementviral bioinsecticidebiocontrolag biotechcorn earworm controlnon-GMO biopesticidecrop protectionsustainable agricultureB2B agricultureUSDA SBIR

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lepidext Comparables

Compare Lepidext with similar companies based on industry and business-model similarity.

Lepidext comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BASF India Limited
78%
Vestaron
76%
Agragene Inc
75%

Lepidext Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 1, 2025
GrantApr 25, 2023
GrantJan 1, 2023
AcceleratorJan 3, 2020

Key People

Founding team and executive leadership

Angelika Fath-Goodin

Co-Founder And COO

Founding Team

Bruce Webb

Chief Executive Officer

Executive Team

Lepidext Investors

Notable investors and investment history

Lepidext investors
InvestorRounds
Kentucky Cabinet for Economic DevelopmentGrant
Ag Ventures AllianceAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 5, 2025

    Grew 50% QoQ from 6 to 9 employees.

  • Apr 14, 2025

    Grew 50% QoQ from 6 to 9 employees.

Lepidext Filings

Explore SEC and related filing metadata, where available.

Lepidext filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Lepidext's valuation, stock price, and market status.

Is Lepidext a public or private company?

Lepidext is a private company.

What is the current stock price of Lepidext?

Lepidext is a private company with no public stock price. No recent secondary market data is available.

How much is Lepidext worth (valuation)?

Valuation information for Lepidext is not publicly available.

Can I buy Lepidext stock?

Lepidext shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Lepidext's last funding round?

Lepidext's most recent funding round was Series A on October 1, 2025.

Who are the main investors in Lepidext?

Key investors in Lepidext include Kentucky Cabinet for Economic Development, Ag Ventures Alliance.

Will Lepidext IPO soon?

No public IPO plans have been announced for Lepidext.

How can I track Lepidext secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Lepidext's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersLexington, Kentucky
Employee Range7
Year Founded2015
Last FundingOct 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?